Test Code LAB124 Testosterone, Total
Useful For
- Evaluation of men with symptoms or signs of possible hypogonadism, such as loss of libido, erectile dysfunction, gynecomastia, osteoporosis, or infertility
 - Evaluation of boys with delayed or precocious puberty
 - Monitoring testosterone replacement therapy
 - Evaluation of women with hirsutism, virilization, and oligoamenorrhea
 - Evaluation of women with symptoms or signs of possible testosterone deficiency
 
Methodology
Electrochemiluminescence Immunoassay (ECLIA)
Performing Laboratory
Bozeman Health Laboratory Services
Specimen Requirements
Specimen Type: Plasma or Serum
Container/Tube: Light green top (Lithium heparin), gold top or red top
Specimen Volume: 2 mL
Specimen Minimum Volume: 1 mL
Specimen Rejection:
- Hemolyzed samples may be rejected.
 - Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration.
 
Specimen Transport Temperature
Ambient/Refrigerated
Specimen Stability
| Specimen Type | Temperature | Time | 
|---|---|---|
| Plasma or Serum | Ambient | 5 days | 
| Refrigerated | 14 days | |
| Frozen | 6 months | 
Reference Values
| Gender | Age | Normal Range | 
|---|---|---|
| Male | ≤9 yrs | 7-29 ng/dL | 
| 10-19 yrs | 
 123-814 ng/dL  | 
|
| 19-40 yrs | 303-852 ng/dL | |
| ≥40 yrs | ≥300 ng/dL | |
| Female | 9-48 ng/dL | 
Additional Information
- Phenylbutazone at therapeutic dosage levels showed interference with this assay (testosterone values increased)
 - Do not use samples from patients under Nandrolone treatment.
 - In isolated cases, elevated testosterone levels can be seen in samples from female patients with end stage renal disease.
 - Implausible elevated testosterone values in women should be verified by an extraction method or a validated LC-MS tandem method.
 
Day(s) Test Set Up
Monday through Friday
Test Classification and CPT Coding
84403